The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 17, issue 9, 2016

Incentivizing research into the effectiveness of medical devices pp. 1055-1058

Michael Drummond, Rosanna Tarricone and Aleksandra Torbica

Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands? pp. 1059-1072

K. P. M. Winssen, R. C. Kleef and W. P. M. M. Ven

Does smoke cross the border? Cigarette tax avoidance in France pp. 1073-1089

Christian Ben Lakhdar, Nicolas Vaillant and François-Charles Wolff

Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland pp. 1091-1100

Mark Fisher, Andrew Walker, Meritxell Falqués, Miguel Moya, Mark Rance, Douglas Taylor and Leandro Lindner

The hidden economic burden of air pollution-related morbidity: evidence from the Aphekom project pp. 1101-1115

Olivier Chanel, Laura Perez, Nino Künzli and Sylvia Medina

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden pp. 1117-1124

J. Banefelt, S. Hallberg, K. M. Fox, J. Mesterton, C. J. Paoli, G. Johansson, L.-Å. Levin, P. Sobocki and S. R. Gandra

What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences pp. 1125-1140

Axel Mühlbacher and Susanne Bethge

The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective pp. 1141-1158

Tobias Effertz, Susanne Engel, Frank Verheyen and Roland Linder

A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure pp. 1159-1172

F. Tomini, F. Prinzen and A. D. I. Asselt

Exploring the determinants of endocrinologist visits by patients with diabetes pp. 1173-1184

Luiz Andrade, Thomas Rapp and Christine Sevilla-Dedieu

Volume 17, issue 8, 2016

Reimbursable drug classes and ceilings in Italy: why not only one? pp. 923-926

Livio Garattini, Alessandro Curto and Anna Padula

Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results pp. 927-938

Theodoros Mantopoulos, Paul M. Mitchell, Nicky J. Welton, Richard McManus and Lazaros Andronis

Multiple imputation strategies for zero-inflated cost data in economic evaluations: which method works best? pp. 939-950

Janet MacNeil Vroomen, Iris Eekhout, Marcel G. Dijkgraaf, Hein van Hout, Sophia E. de Rooij, Martijn W. Heymans and Judith E. Bosmans

A cost analysis of orthopedic foot surgery: can outpatient continuous regional analgesia provide the same standard of care for postoperative pain control at home without shifting costs? pp. 951-961

Andrea Saporito, Stefano Calciolari, Laura Gonzalez Ortiz, Luciano Anselmi, Alain Borgeat and José Aguirre

The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study pp. 963-977

Patrizio Armeni, Claudio Jommi and Monica Otto

The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation pp. 979-990

Louis S. Matza, Kristina S. Boye, David H. Feeny, Lee Bowman, Joseph A. Johnston, Katie D. Stewart, Kelly McDaniel and Jessica Jordan

Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach pp. 991-999

Elena Nicod, Timothy L. Jackson, Federico Grimaccia, Aris Angelis, Marc Costen, Richard Haynes, Edward Hughes, Edward Pringle, Hadi Zambarakji and Panos Kanavos

Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain pp. 1001-1010

Manel Mata-Cases, Marc Casajuana, Josep Franch-Nadal, Aina Casellas, Conxa Castell, Irene Vinagre, Dídac Mauricio and Bonaventura Bolíbar

Is higher nursing home quality more costly? pp. 1011-1026

L. Di Giorgio, Massimo Filippini and Giuliano Masiero

The diffusion of generics after patent expiry in Germany pp. 1027-1040

Katharina Elisabeth Fischer and Tom Stargardt

Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature pp. 1041-1053

David Epstein, Leticia García-Mochón, Stephen Kaptoge and Simon G. Thompson

Volume 17, issue 7, 2016

Improving health care systems by building ‘more Europe’ pp. 787-789

F. Antoñanzas, C. A. Juárez-Castelló and R. Rodríguez-Ibeas

Multiple sclerosis: relapses, resource use, and costs pp. 875-884

A. J. Hawton and C. Green

Marginal revenue and length of stay in inpatient psychiatry pp. 897-910

Mark Pletscher

OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales pp. 911-921

Nick Freemantle, Kristin Khalaf, Clara Loveman, Sanja Stanisic, Dmitry Gultyaev, Johanna Lister and Marcus Drake

Volume 17, issue 6, 2016

The demand for health insurance and behavioural economics pp. 653-657

K. P. M. van Winssen, R. C. van Kleef and W. P. M. M. van de Ven

Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation pp. 659-668

Bernadette Li, John Cairns, James Fotheringham and Rommel Ravanan

Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013 pp. 669-679

Jennifer Haas, Sebastian Braun and Peter Wutzler

Forecasting the use of elderly care: a static micro-simulation model pp. 681-691

Evelien Eggink, Isolde Woittiez and Michiel Ras

Health, work and working conditions: a review of the European economic literature pp. 693-709

Thomas Barnay

Health resource utilization associated with skeletal-related events: results from a retrospective European study pp. 711-721

Jean-Jacques Body, João Pereira, Harm Sleeboom, Nikos Maniadakis, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, Oliver Gunther, Guy Hechmati, Tony Mossman, Luis Costa, Wojciech Rogowski, Hareth Nahi and Roger Moos

The true impact of the French pay-for-performance program on physicians’ benzodiazepines prescription behavior pp. 723-732

Audrey Michel-Lepage and Bruno Ventelou

Estimating informal care inputs associated with EQ-5D for use in economic evaluation pp. 733-744

Donna Rowen, Simon Dixon, Mónica Hernández-Alava and Clara Mukuria

Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway pp. 745-754

Tron A. Moger, Gudrun M. W. Bjørnelv and Eline Aas

Economic evaluation in chronic pain: a systematic review and de novo flexible economic model pp. 755-770

W. Sullivan, M. Hirst, S. Beard, D. Gladwell, F. Fagnani, J. López Bastida, C. Phillips and W. C. N. Dunlop

Pay or conditions? The role of workplace characteristics in nurses’ labor supply pp. 771-785

Barbara Eberth, Robert F. Elliott and Diane Skåtun

Volume 17, issue 5, 2016

‘Catastrophic’ healthcare expenditure: critique of a problematic concept and a proposal pp. 519-520

Peter Zweifel

Volume 17, issue 4, 2016

Prioritizing health services research: an economic perspective pp. 375-377

Afschin Gandjour

Volume 17, issue 3, 2016

Competition among health care providers: helpful or harmful? pp. 229-233

Pedro Barros, Werner Brouwer, Sarah Thomson and Marco Varkevisser

Erratum to: Treatment costs of attention deficit hyperactivity disorder in Germany pp. 371-373

Sebastian Braun, Jan Zeidler, Roland Linder, Susanne Engel, Frank Verheyen and Wolfgang Greiner

Volume 17, issue 2, 2016

Access to primary care in Italy: time for a shake-up? pp. 113-116

Livio Garattini, Alessandro Curto and Nick Freemantle

Are some QALYs more equal than others? pp. 117-127

E. Wetering, Job van Exel, John Rose, R. Hoefman and Werner Brouwer

Economic hardship and suicide mortality in Finland, 1875–2010 pp. 129-137

Marko Korhonen, Mikko Puhakka and Matti Viren

The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach pp. 139-147

Andrea Marcellusi, Raffaella Viti, A. Mecozzi and Francesco Saverio Mennini

Willingness to pay for health insurance among the elderly population in Germany pp. 149-158

Jens-Oliver Bock, Dirk Heider, Herbert Matschinger, Hermann Brenner, Kai-Uwe Saum, Walter Haefeli and Hans-Helmut König

Informal payments in the Greek health sector amid the financial crisis: old habits die last pp. 159-170

Kyriakos Souliotis, Christina Golna, Yannis Tountas, Olga Siskou, Daphne Kaitelidou and Lycourgos Liaropoulos

Do insurers respond to risk adjustment? A long-term, nationwide analysis from Switzerland pp. 171-183

Viktor von Wyl and Konstantin Beck

Understanding the economic impact of intravascular ultrasound (IVUS) pp. 185-193

Alessandro Alberti, Pietro Giudice, Alessandra Gelera, Luca Stefanini, Virginia Priest, Michael Simmonds, Christa Lee and Matthew Wasserman

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis pp. 195-201

Christian Jacob, Benno Bechtel, Susanne Engel, Peter Kardos, Roland Linder, Sebastian Braun and Wolfgang Greiner

Lessons from state mandates of preventive cancer screenings pp. 203-215

Wendy Xu, Bryan Dowd and Jean Abraham

Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine pp. 217-227

Alexander Hirst, Chris Knight, Matt Hirst, Will Dunlop and Ron Akehurst

Volume 17, issue 1, 2016

Social/economic costs and health-related quality of life in patients with rare diseases in Europe pp. 1-5

Julio López-Bastida, Juan Oliva, Renata Linertová and Pedro Serrano-Aguilar

Ebola fever epidemic 2014: a call for sustainable health and development policies pp. 1-4

Steffen Flessa and Michael Marx

Differences in price elasticities of demand for health insurance: a systematic review pp. 5-21

Jonas Pendzialek, Dusan Simic and Stephanie Stock

Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe pp. 7-18

Karine Chevreul, Morgane Michel, Karen Berg Brigham, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, Márta Péntek, Johann Matthias Graf Schulenburg, Panos Kanavos, Ulf Persson and Giovani Fattore

Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe pp. 19-29

Marianna Cavazza, Yllka Kodra, Patrizio Armeni, Marta Santis, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, Márta Péntek, Johann Matthias Graf Schulenburg, Panos Kanavos, Karine Chevreul, Ulf Persson and Giovanni Fattore

Is response to price equal for those with higher alcohol consumption? pp. 23-29

Joshua Byrnes, Anthony Shakeshaft, Dennis Petrie and Christopher Doran

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe pp. 31-42

Aris Angelis, Panos Kanavos, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, Valentin Brodszky, Johann Matthias Graf Schulenburg, Karine Chevreul, Ulf Persson and Giovanni Fattore

Estimating productivity costs using the friction cost approach in practice: a systematic review pp. 31-44

Jesse Kigozi, Sue Jowett, Martyn Lewis, Pelham Barton and Joanna Coast

Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe pp. 43-52

Karine Chevreul, Coralie Gandré, Karen Berg Brigham, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, László Gulácsi, Johann Matthias Graf Schulenburg, Panos Kanavos, Ulf Persson and Giovani Fattore

Entry time effects and follow-on drug competition pp. 45-60

Luiz Andrade, Catherine Sermet and Sylvain Pichetti

Social/economic costs and quality of life in patients with haemophilia in Europe pp. 53-65

Marianna Cavazza, Yllka Kodra, Patrizio Armeni, Marta De Santis, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, László Gulácsi, Johann Matthias Graf Schulenburg, Panos Kanavos, Karine Chevreul, Ulf Persson and Giovanni Fattore

Health care costs attributable to overweight calculated in a standardized way for three European countries pp. 61-69

M. Lette, W. Bemelmans, J. Breda, L. Slobbe, J. Dias and H. Boshuizen

Social/economic costs and health-related quality of life in patients with histiocytosis in Europe pp. 67-78

Georgi Iskrov, Itziar Astigarraga, Rumen Stefanov, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Arrigo Schieppati, Domenica Taruscio, Márta Péntek, Johann Matthias Graf Schulenburg, Panos Kanavos, Karine Chevreul, Ulf Persson and Giovanni Fattore

Wage subsidies and hiring chances for the disabled: some causal evidence pp. 71-86

Stijn Baert

Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe pp. 79-87

A. Kuhlmann, T. Schmidt, M. Treskova, J. López-Bastida, R. Linertová, Juan Oliva, P. Serrano-Aguilar, M. Posada- de-la-Paz, P. Kanavos, D. Taruscio, A. Schieppati, G. Iskrov, Márta Péntek, C. Delgado, Johann Graf von der Schulenburg, U. Persson, K. Chevreul and G. Fattore

The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal pp. 87-98

Luís Azevedo, Altamiro Costa-Pereira, Liliane Mendonça, Cláudia Dias and José Castro-Lopes

Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe pp. 89-98

Márta Péntek, László Gulácsi, Valentin Brodszky, Petra Baji, Imre Boncz, Gábor Pogány, Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Domenica Taruscio, Georgi Iskrov, Arrigo Schieppati, Johann Matthias Graf Schulenburg, Panos Kanavos, Karine Chevreul, Ulf Persson and Giovanni Fattore

Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe pp. 99-108

Julio López-Bastida, Renata Linertová, Juan Oliva, Manuel Posada- de-la-Paz, Pedro Serrano-Aguilar, Panos Kanavos, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, Petra Baji, Claudia Delgado, Johann Matthias Graf Schulenburg, Ulf Persson, Karine Chevreul and Giovanni Fattore

Is the United States in the middle of a healthcare bubble? pp. 99-111

Wen-Yi Chen, Yia-Wun Liang and Yu-Hui Lin

Social/economic costs and health-related quality of life in patients with scleroderma in Europe pp. 109-117

Julio López-Bastida, Renata Linertová, Juan Oliva, Pedro Serrano-Aguilar, Manuel Posada- de-la-Paz, Panos Kanavos, Domenica Taruscio, Arrigo Schieppati, Georgi Iskrov, Márta Péntek, Claudia Delgado, Johann Mathias Schulenburg, Ulf Persson, Karine Chevreul and Giovanni Fattore